Date :

Time :

Biotechnology
- Biotech. News
  - NIH
  - Millipore
  - Amphinex®
  - Myeloma
  - Oramed Pharma
  - Biopharma
  - SAFC Bio
  - Zimmer Institute
  - Heart Disease
  - BioMask
  - S1P1
  - Mobius FlexReady
  - Cardiovascular
  - 3SBio Inc
  - CBP
- Biotech. Releases
  - AMSBIO
  - GE Healthcare
  - GATC Biotech
  - Novartis
  - Boehringer
  - Lonza
  - Inovio Biomedical
  - GSK
  - Oracle
  - CRC
  - Novalis Tx
  - MM 121
  - MM 121
  - Biotech Hub
  - EUCODIS
- Biotech. Profile
- Research Paper
  - Medigene GmbH
  - Angiogenesis
  - Big Bang
  - ACI
  - Biology
  - Cell Body
  - Non-steroidal
Drug Discovery
- Drug News
  - NIH
  - Abbott
  - NIH
  - Optiferrin
  - Novel Compounds
  - Mind Research
  - Denosumab
  - Zimmer Institute
  - Embryo Gene
  - Gonal f
  - Siemens
  - Solvay
  - drug targets
  - GSK
  - NeoStem
- Drug Releases
  - CRC
  - TB Drug
  - 3SBio
  - Repligen
  - Shenzhen Beike
  - GlycoMimetics
  - VALSTAR(TM)
  - Stem Cell
  - siRNA
  - RNAi
  - Inovio
  - drug P2045
  - Inovio
  - Eli Lilly and Compan
  - MabThera
- Drug Profile
- Research Paper
CRO
- CRO News
- CRO Releases
  - Oracle
  - Clinical xPress
  - SIRO Clinpharm
  - PATH Malaria
  - PPD
  - Kendle
  - SIRO
  - Porvair
  - PAREXEL
  - DNA Testing
  - Toxicology
  - India's CRO
  - Covance
  - WuXi Pharma
  - Quintiles
- CRO Profile
- Research Paper
Generic Drugs
- Generic News
- Generic Releases
  - Actelion Ltd
  - Covidien
  - Veregen®
  - Atripla(R)
  - AOB
  - NUVADERM
  - Fludarabine
  - Radezolid
  - Covidien
  - Erbitux
  - BioMarin Pharma
  - Avastin
  - Cytomel
  - Sanofi aventis
  - GSK’
- Generic Profile
  - Sanofi
  - Alcon
  - Novartis
  - Teva
  - Dr.Reddy's
- Research Paper
  - Mylan
  - FDA
  - Sandoz
Clinical Dev.
- Clinical News
  - Chemotherapy
  - QVA149
  - Global Pharma
  - HTDS
  - MorphoSys AG
  - Reg Standards
  - Tiotropium
  - Hormonal
  - Tovok™
  - Zimmer Institute
  - BioMarin
  - Sosei
  - O2h
  - Spherix
  - BVA 601
- Clinical Releases
  - Inovio
  - InterMune
  - Lonza
  - MediGene AG
  - Vitae Pharma
  - Almac
  - Prulifloxacin
  - Amgen Inc
  - IMPROVE
  - Covance Inc
  - ASBMR
  - CBI
  - LigoCyte
  - CYT387
  - Karolinska
- Clinical Profile
- Research Paper
QA/QC & Trends
- QA/QC News
  - PPD
  - ParagonRx
  - ALIMTA(R)
  - MDS Inc
  - Dr M Group
  - Abbott
  - Bioheart Inc
  - Merck
  - MorphoSys AG
  - ValGenesis Inc
  - Avid Bioservices
  - Acoris
  - Bio Development
  - Zimmer Institute
  - PROLOR
- QA/QC Releases
  - AMSBIO
  - Actelion Ltd
  - Novartis
  - Boehringer
  - BioMarin
  - GSK
  - Oracle
  - BioWa Inc
  - CRC
  - Sunesis Pharma
  - Arena Pharma
  - PROcellcare®
  - Biacore™ X100
  - PharmAbcine
  - Sinovac
- QA/QC Profile
- Research Paper
Editorial
- Perspectives
- Monthly Products
Events
Your Services
Advertise
- Advertising Info
- Online Booking

Advertising : Place your textual ad here - Latest News headlines : First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines - PPD Launches New Global Biostatistics Technology Infrastructure - Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain -

Licensing Agreement On MM-121, An Anti-ErbB3 Monoclonal Antibody

By Merrimack Pharmaceuticals

Publication date : Monday, 05 October 2009

Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today the signing of an exclusive

NEW SERVICE !

pharmaceutical press release publication

PRODUCT AWARD

PERSPECTIVES

OFFICIAL PARTNERS

ICSE Partner

PMEC Partner

Bio Manufacturing Summit Partner

American Conference Institute Partner

WTP partner

NEW! Send your Press Release for publication - Related Pharmaceutical websites : Asia Manufacturing Pharma | Pharmaceutical Manufacturing News

Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing | QA/QC | Pharma Strategy | Drug Discovery | Biotechnology | Clinical Dev.

Subscribe to Asia-Lifesiences.com | Unsubscribe from Asia-Lifesiences.com | Advertise | Privacy Statement | Copyright | Contact the publisher of this site

© Intelligent Publishing Media 2009 - All rights reserved.